Loading...
New Cell Sources for T Cell Engineering and Adoptive Immunotherapy
The promising clinical results obtained with engineered T cells, including chimeric antigen receptor (CAR) therapy, call for further advancements to facilitate and broaden their applicability. One potentially beneficial innovation is to exploit new T cell sources that reduce the need for autologous...
Saved in:
Published in: | Cell Stem Cell |
---|---|
Main Authors: | , , |
Format: | Artigo |
Language: | Inglês |
Published: |
2015
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5611846/ https://ncbi.nlm.nih.gov/pubmed/25842976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.stem.2015.03.011 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|